Study on the Effect and Value of Guizhi Licorice Dragon Bone Oyster Modified Decoction in the Treatment of Ventricular Premature Beats in Coronary Heart Disease

Journal: Journal of Clinical Medicine Research DOI: 10.32629/jcmr.v5i4.3312

Ting Wang, Luning Bai

Shaanxi University of Traditional Chinese Medicine, Xianyang 712000, Shaanxi, China

Abstract

Objective: To investigate the efficacy and value of Guizhi Gancao Longgu Muli Jiawei Tang in the treatment of premature ventricular complexes (PVCs) in coronary heart disease. Method: From January 2022 to August 2024, 96 patients with PVCs in our hospital were selected as the research subjects. The patients were randomly divided into a reference group (n=48, treated with conventional therapy) and a study group (n=48, treated with Guizhi Gancao Longgu Muli Jiawei Tang) using a random number table method. Compare the clinical efficacy, pre - and post-treatment electrocardiogram indicators, blood lipid levels (triglycerides, low-density lipoprotein, high-density lipoprotein), traditional Chinese medicine syndrome scores, and incidence of adverse reactions between two groups. The total clinical effective rate of the research group was 95.83% (46/48), which was higher than the reference group's 75.00% (36/48), and the difference was significant (P<0.05). The electrocardiogram of the research group was superior to that of the reference group, with a significant difference (P<0.05). After treatment, the levels of triglycerides, low-density lipoprotein, and high-density lipoprotein in the study group were significantly lower than those in the reference group (P<0.05). After treatment, the TCM syndrome score of the study group was lower than that of the reference group, and the difference was significant (P<0.05). The incidence of adverse reactions in the study group (2.08%) was significantly different from that in the reference group (16.66%) (P<0.05). Conclusion: Guizhi Licorice Dragon Bone Oyster Modified Decoction has a significant effect in assisting the treatment of PVCs, which can effectively improve the condition, alleviate clinical symptoms, regulate blood lipid levels, and reduce the incidence of adverse reactions.

Keywords

Guizhi Licorice Dragon Bone Oyster Modified Soup; Coronary heart disease; Ventricular premature beats

References

[1] Liu Yaqin, Li Shuling, Qi Quan. Clinical Observation of Shensong Yangxin Capsules in the Treatment of Elderly Patients with Ventricular Premature Beats, Qi Yin Deficiency, and Heart Meridian Stasis in Coronary Heart Disease [J]. Western Traditional Chinese Medicine, 2024, 37 (4): 139-141.
[2] Qin Nian, Zhang Cangyun, Yang Qingxia, etc. Observation on the therapeutic effect of Shenxia Buqi Formula combined with ear acupressure on ventricular premature beats with qi deficiency and phlegm obstruction syndrome in coronary heart disease [J]. Journal of Modern Integrated Traditional Chinese and Western Medicine, 2022,31 (16): 2289-22922320.
[3] Hao Lili, Lu Ruihua, Tang Wenxin. Clinical effect of Shensong Yangxin capsule combined with metoprolol in the treatment of ventricular premature beats in coronary heart disease [J]. Contemporary Chinese Medicine, 2022, 29 (1): 60-63.
[4] Shen Chong. Analysis of the therapeutic effect of Guizhi Gancao Longgu Muli Jiawei Tang on ventricular premature beats in coronary heart disease [J]. Chinese Journal of Modern Drug Application, 2023, 17 (4): 15-18.
[5] Chinese Medical Association Cardiovascular Disease Branch. Guidelines for Diagnosis and Treatment of Chronic Stable Angina Pectoris [J]. Chinese Journal of Cardiovascular Disease, 2007, 35 (3): 195-206.
[6] Chinese Medical Association Electrophysiology and Pacing Branch, Chinese Medical Association Rhythmology Professional Committee. 2020 Chinese Expert Consensus on Ventricular Arrhythmia (2016 Consensus Upgraded Version) [J]. Chinese Journal of Cardiac Pacing and Electrophysiology, 2020, 34 (3): 189-253.
[7] Chinese Association of Traditional Chinese Medicine. Guidelines for Diagnosis and Treatment of Common Diseases in Traditional Chinese Medicine Internal Medicine Western Medicine Diseases Part - Ventricular Premature Beats [M]. Beijing: China Traditional Chinese Medicine Press, 2008:55-57.
[8] Zheng Xiaoyu. Guidelines for Clinical Research of Traditional Chinese Medicine New Drugs (Trial) [M]. Beijing: China Medical Science and Technology Press, 2002:78-80.
[9] Liu Jie, Yan Xuejiao, Zhu Tiantian. The clinical efficacy of Shensong Yangxin capsules combined with amiodarone hydrochloride tablets in the treatment of ventricular premature beats in coronary heart disease and their effects on serum NO and TXB2 levels [J]. Chinese Journal of Traditional Chinese Medicine, 2023, 41 (12): 82-85.
[10] Chen Jianqiang, Chen Zhilong, Liu Xin, etc. The effect of Yiqi Yangxin Tang on left ventricular function, peripheral blood endothelial progenitor cells, and autonomic nervous system imbalance in patients with coronary heart disease and ventricular premature beats (Qi deficiency and blood stasis type) [J]. Journal of Liaoning University of Traditional Chinese Medicine, 2022, 24 (2): 66-70.
[11] Lu Yan. Clinical observation of Guizhi Licorice Longgu Oyster soup in treating ventricular premature beats of coronary heart disease [J]. Modern Distance Education of Traditional Chinese Medicine in China, 2023, 21 (4): 97-99.
[12] Jiang Yanyan, Xiao Hongfang. The effect of sodium tanshinone IIA sulfonate combined with statins on inflammatory factors and coagulation function in patients with coronary heart disease [J]. Medical Clinical Research, 2024, 41 (1): 129-131.
[13] Xie Caiyang, Fu Peilei, Feng Shuang. Exploring the mechanism of Guizhi in treating coronary heart disease based on network pharmacology [J] Industrial Microbiology, 2024, 54 (4): 147-150.

Copyright © 2025 Ting Wang, Luning Bai

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License